The College of Law Innovation Law Center performed a recent patent analysis for the new medical technology startup JelikaLite, a company focusing on pediatric neurological health that is working to develop a treatment for autism. JelikaLite’s new treatment, Cognilum, received “Breakthrough Device Designation” from the FDA in January and is on the path to go to market post-clinical trials.
Co-founder and CEO Katya Sverdlov obtained important backing and support for Cognilum from Upstate Medical University’s CNY Biotech Accelerator in Syracuse, selected as a winner at this year’s annual Medical Device Innovation Challenge (MDIC).
Kathi Durdon, Director of Operations for the Biotech Accelerator, then connected Sverdlov to the SU Innovation Law Center for Cognilum’s patent needs.
Sverdlov explains, “we did have patent attorneys, but the last time they did patent analysis for us was two years ago. I was terrified that something had happened, but the SU law center did absolutely wonderful analysis for us with really good feedback on our possibilities on the patent.”